Clinical trials play a critical role in ensuring the widespread safety of medical products for patients by analyzing product efficacy, safety, and indications. Since clinical trial data is used to guide drug approvals and standards of care...
On November 16, 2023, the United States Food and Drug Administration approved AstraZeneca’s Truqap (capivasertib) to be administered in combination with fulvestrant for adults with hormone...
Since its inception, artificial intelligence (AI) has continually disrupted practices across all industries. As more and more healthcare researchers and clinicians adopt AI, experts have noted the impact of AI on clinical research and...
On November 1, 2023, the Global Antibiotic Research and Development Partners (GARDP) and Innoviva Specialty Therapeutics, a subset of Innoviva Inc, issued a co-authored press release announcing that a...
In the realm of healthcare technology, one of the most critical and revolutionary aspects is the process of tracking and analyzing clinical trial data. Clinical trials are the backbone of medical advancements, paving the way for...
Yesterday, the New England Journal of Medicine published the results of a randomized study, which revealed that semaglutide can help manage heart failure symptoms in obese patients with preserved...
Yesterday, the National Institute of Allergy and Infectious Disease (NIAID), a subset of the National Institutes of Health (NIH), revealed that phase 1 vaccine trials for human immunodeficiency virus...
Defining clinically meaningful data can be complicated, as different stakeholders may have variable definitions depending on their demographics, needs, and perspectives. Understanding how various stakeholders may define clinically...
According to the Seven Pillars Institute for Global Finance and Ethics, various ethical issues are pressing the pharmaceutical industry and its stakeholders, including researchers, pharmacists, pharmaceutical companies, other healthcare...
A new study published in the Lancet provides a new route for improving the effectiveness of oral emergency contraceptives. According to the study, taking an anti-inflammatory pill alongside Plan B...
On Monday, Nektar Therapeutics released a scathing public statement that accused its former partner, Eli Lilly, of miscalculating and sharing clinical trial results that underrepresented the...
On August 2, 2023, Altogen Biosystems announced and launched a new targeted reagent that can deliver biomolecules to the lungs, treating pulmonary diseases. According to the announcement, the drug has...
On July 28, 2023, the United States Food and Drug Administration (FDA) approved ReVive, an opioid reversal medication manufactured by Harm Reduction Therapeutics, a nonprofit pharmaceutical company. The concept of a nonprofit...
A study published in the American Journal of Psychiatry on July 26, 2023, proved that zuranolone could effectively and safely treat postpartum depression. The study supports the priority review granted...
In a research letter published in JAMA Network Open on July 25, 2023, scientists evaluated data availability from pediatric clinical trials funded by the National Institutes of Health (NIH). According...
Addressing the top 10 most common myths about medicinal and recreational cannabis is critical to promote informed decision-making, reduce stigma, and foster evidence-based discussions, leading to safer use and better public policies....
Throughout the past decade, psychedelics have become a primary area of interest for ongoing clinical research. Scientists have hypothesized multiple clinical use cases for these medications despite primarily being scheduled or illicit...
On July 17, 2023, the FDA added to the arsenal of respiratory syncytial virus (RSV) prevention tools by approving Beyfortus, a monoclonal antibody for preventing the infection in children two years old...
A study published last week in the New England Journal of Medicine concluded that BRAF–MEK inhibitors — traditionally used in melanoma treatment — can shrink papillary...
On July 6, 2023, the FDA granted Biogen Inc and Eisai Co’s Lequembi traditional FDA approval. The approval was based on a supplemental Biologics License Application (sBLA) and prior accelerated...
